SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE;SALK INSTITUTE FOR BIOLOGICAL STUDIES;YALE UNIVERSITY
发明人:
Reuben J. Shaw,Daniel F. Egan,Nicholas Cosford,Benjamin Turk,Mitchell Vamos,Dhanya Raveendra Panickar,Matthew Chun,Douglas Sheffler
申请号：
US16389784
公开号：
US10774092B2
申请日:
2019.04.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
In certain aspects, the invention provides a method for treating a disease or condition in a subject, the method comprising co-administering to a subject in need thereof a therapeutically effective amount of at least one ULK1-inhibiting pyrimidine, and a therapeutically effective amount of an mTOR inhibitor.
